Are Bioidentical Hormones Safer Than Traditional HRT?

No. There is no evidence that "bioidentical" hormones are safer than standard hormone replacement therapy (HRT). The more useful distinction is FDA-approved versus compounded: several FDA-approved HRT products already are bioidentical, while custom-compounded versions have not been shown to be safer or more effective and carry extra uncertainty about dose and purity (Mayo Clinic, n.d.; National Academies of Sciences, Engineering, and Medicine [NASEM], 2020).

What This Means

"Bioidentical" describes a hormone with the same molecular structure as the one your body makes, such as estradiol, progesterone, or testosterone (Stuenkel, 2021). It is a chemistry term, not a safety rating.

The word gets confusing because it is used two different ways. FDA-approved products such as estradiol patches, gels, and vaginal inserts, and micronized progesterone capsules, are bioidentical. So are many compounded creams, pellets, and troches made to order by a compounding pharmacy. The molecule can be identical while the oversight is not (Cleveland Clinic, n.d.).

"Traditional" HRT usually refers to older FDA-approved products such as conjugated equine estrogens or synthetic progestins. Those are also approved, tested, and labeled. The safety question, then, is really about how a product is made and monitored, not whether it carries the bioidentical label.

Candidacy

Whether any form of HRT is appropriate depends on the person, not the product. The Menopause Society's position statement supports hormone therapy for bothersome hot flashes and night sweats, genitourinary symptoms, and bone loss in appropriate patients, with the most favorable benefit-risk profile in women under 60 or within 10 years of menopause onset (The Menopause Society, 2022).

A history of breast cancer, blood clots, stroke, heart attack, or active liver disease changes the calculation and may rule therapy out. Those considerations apply equally to bioidentical and non-bioidentical products.

Clinical Evaluation

At PrimeCell Regenerative, an evaluation for hormone therapy starts with symptoms, medical history, and family history, followed by laboratory testing where it helps. For menopause, symptoms guide the decision more than a single hormone level. For men with suspected low testosterone, morning blood levels on more than one occasion are standard before a prescription is considered.

One point worth knowing: salivary and blood hormone testing is sometimes marketed as a way to "customize" compounded doses. The Menopause Society does not recommend routine hormone-level testing to titrate menopausal therapy, because levels fluctuate and do not track well with symptom relief (The Menopause Society, 2022).

Available Options

FDA-approved bioidentical products are the mainstream option. Estradiol is available as patches, gels, sprays, oral tablets, vaginal creams, tablets, and rings. Micronized progesterone is available as an oral capsule. For men, FDA-approved testosterone comes as gels, injections, patches, nasal gel, and implantable pellets.

FDA-approved non-bioidentical products include conjugated estrogens and synthetic progestins such as medroxyprogesterone. These have the longest track record in large trials.

Compounded bioidentical hormone therapy (cBHT) includes custom creams, capsules, troches, and pellets prepared by a pharmacy for an individual patient. Compounding has a legitimate role when a patient is allergic to an ingredient in an approved product or needs a dose or form that is not commercially made (NASEM, 2020). It is not a substitute for approved products when one would do.

Non-hormonal options also exist. FDA-approved non-hormonal medications for hot flashes, vaginal moisturizers, and lifestyle changes are reasonable for people who cannot or prefer not to use hormones.

Benefits, Limitations and Risks

FDA-approved HRT, bioidentical or not, is the most effective option for moderate to severe hot flashes and night sweats, and it helps protect bone (The Menopause Society, 2022). Risks include blood clots, stroke, gallbladder disease, and, with combined estrogen-progestogen therapy used for several years, a small increase in breast cancer risk. Transdermal estradiol appears to carry less clotting risk than oral forms in observational data.

Compounded products carry the same hormone-related risks plus additional ones. Compounded drugs are not FDA-approved, are not tested for safety or effectiveness before sale, and are not held to the same manufacturing standards, so potency and absorption can vary from batch to batch (U.S. Food and Drug Administration [FDA], 2020). NASEM found that adverse events with cBHT are underreported, and the Menopause Society notes case reports of endometrial cancer in women using compounded estrogen with inadequate progesterone (Stuenkel, 2021; The Menopause Society, 2022).

Pellets deserve a specific mention. Compounded hormone pellets can produce blood levels well above the physiologic range, and once implanted they cannot be removed if side effects appear (Stuenkel, 2021).

What the Evidence Shows

What the evidence does establish: FDA-approved hormone therapies have been tested in large randomized trials. In February 2026, the FDA approved label changes that removed boxed warnings about cardiovascular disease, breast cancer, and probable dementia from several menopausal hormone products, citing data that women who start therapy within 10 years of menopause have lower all-cause mortality and fewer fractures (FDA, 2026). The endometrial cancer warning for estrogen-alone products was retained.

What the evidence does not establish: that compounded bioidentical hormones are safer, more natural in effect, or more effective than approved products. In its 2020 review commissioned by the FDA, NASEM concluded there was insufficient evidence of safety or effectiveness to support the widespread use of cBHT, and that most claims came from low-quality sources such as testimonials and prescriber reports (NASEM, 2020; FDA, 2020). Mayo Clinic and Cleveland Clinic summaries reach the same conclusion (Cleveland Clinic, n.d.; Mayo Clinic, n.d.).

Put simply, the label "bioidentical" tells you about the molecule. It does not tell you the product was tested.

Recovery / Next Steps

Hormone therapy is an ongoing prescription, not a one-time procedure. After starting, a follow-up visit at roughly 6 to 12 weeks checks symptom response and side effects, with dose adjustments as needed. Ongoing care includes annual review of whether therapy is still appropriate, along with routine breast and pelvic health screening.

If you are already using a compounded product, do not stop abruptly on your own. Bring the prescription details to an evaluation so a physician can review the dose and decide whether an FDA-approved equivalent makes sense.

Orlando Considerations

In Florida, hormone therapy is prescribed by licensed physicians, physician assistants, and advanced practice registered nurses under state scope-of-practice law. Compounding pharmacies are licensed by the Florida Board of Pharmacy, and the FDA also regulates outsourcing facilities under federal law. PrimeCell Regenerative offers physician-led hormone care at its Orlando office, and telemedicine follow-ups where clinically appropriate.

Frequently Asked Questions

Are bioidentical hormones FDA-approved?

Some are. Estradiol and micronized progesterone are FDA-approved bioidentical hormones. Compounded bioidentical products are not FDA-approved, though the pharmacies that make them are regulated by state boards and, for outsourcing facilities, the FDA.

Do bioidentical hormones have fewer side effects than synthetic ones?

There is no good evidence that they do. Approved bioidentical and non-bioidentical products carry the same class of risks. Some studies suggest transdermal estradiol has a lower clotting risk than oral estrogen, but that is a route difference, not a bioidentical difference.

Is compounded HRT ever the right choice?

Occasionally. NASEM identified two legitimate reasons: a documented allergy to an ingredient in an approved product, or a need for a dose or form that is not commercially available (NASEM, 2020).

Are hormone pellets bioidentical, and are they safe?

Most pellets are compounded estradiol or testosterone, which is bioidentical. FDA-approved testosterone pellets exist for men. Compounded pellets have produced blood hormone levels above the normal range in studies, and they cannot be removed once placed, which is why many menopause specialists advise caution (Stuenkel, 2021).

Did the FDA say HRT is now safe for everyone?

No. The 2026 label changes removed certain boxed warnings for approved products, but risks still exist and vary by age, health history, and time since menopause. Candidacy is decided with a licensed physician after evaluation.

This article is for general education and is not medical advice. Hormone replacement therapy is a regulated prescription therapy that requires an evaluation, laboratory testing where indicated, and ongoing monitoring. Individual results vary. Treatment options are discussed after a medical evaluation.

Medically reviewed by Kenny Chantasi, DO.

References

Cleveland Clinic. (n.d.). Bioidentical hormones. https://my.clevelandclinic.org/health/treatments/15660-bioidentical-hormones

Mayo Clinic. (n.d.). Bioidentical hormones: Are they safer? https://www.mayoclinic.org/diseases-conditions/menopause/expert-answers/bioidentical-hormones/faq-20058460

National Academies of Sciences, Engineering, and Medicine. (2020). The clinical utility of compounded bioidentical hormone therapy: A review of safety, effectiveness, and use. The National Academies Press. https://doi.org/10.17226/25791

Stuenkel, C. A. (2021). Compounded bioidentical hormone therapy: New recommendations from the 2020 National Academies of Sciences, Engineering, and Medicine. Menopause, 28(5), 576–578. https://doi.org/10.1097/GME.0000000000001735

The Menopause Society. (2022). The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 29(7), 767–794. https://doi.org/10.1097/GME.0000000000002028

U.S. Food and Drug Administration. (2020, July 1). National Academies of Science, Engineering, and Medicine (NASEM) study on the clinical utility of treating patients with compounded "bioidentical" hormone therapy. https://www.fda.gov/drugs/human-drug-compounding/national-academies-science-engineering-and-medicine-nasem-study-clinical-utility-treating-patients

U.S. Food and Drug Administration. (2026, February 12). FDA approves labeling changes to menopausal hormone therapy products [Press release]. https://www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-products

Last medically reviewed: September 3, 2026.

Related reading

• Who Is a Good Candidate for Hormone Replacement Therapy?
• How Hormone Therapy Works: Pellets vs. Injection Hormones
• When Should You Start Hormone Replacement Therapy?
• Does Insurance Cover Hormone Replacement Therapy?

More questions answered on the PrimeCell patient blog, or see frequently asked questions.

Related services at PrimeCell

PrimeCell is a physician-led practice in Orlando. Candidacy for any procedure is determined at an in-person evaluation.